How to Get Losartan in Arkansas

What Losartan Is and Why Arkansas Patients Use It

Losartan is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking AT1 receptors in vascular smooth muscle and the adrenal gland. The FDA approved losartan potassium (brand: Cozaar) in 1995 for hypertension, and the label was later expanded to cover diabetic nephropathy in patients with type 2 diabetes and left ventricular hypertrophy [1]. Generic formulations from multiple manufacturers are now available and carry identical labeling to the original Merck product.

The LIFE trial (N=9,193, Lancet 2002) compared losartan 50 to 100 mg against atenolol 50 to 100 mg over a mean 4.8 years in patients with hypertension and electrocardiographic left ventricular hypertrophy. Losartan produced a 13% relative risk reduction in the composite endpoint of cardiovascular death, stroke, and myocardial infarction (P<0.001 vs. atenolol), driven largely by a 25% reduction in fatal and non-fatal stroke [2]. That stroke-reduction signal helped establish ARBs as a first-line antihypertensive class in patients with comorbid left ventricular hypertrophy.

Arkansas has a hypertension prevalence of approximately 38% among adults, above the national average of 34% reported by CDC surveillance data [3]. Heart failure and diabetic kidney disease, both conditions for which losartan carries FDA label indications, are also disproportionately prevalent in the state [4]. Those epidemiologic realities make losartan one of the most commonly dispensed medications at Arkansas retail pharmacies.

The 2023 ACC/AHA Hypertension Guideline identifies ARBs as a preferred antihypertensive class in patients with chronic kidney disease, heart failure with reduced ejection fraction, and diabetes, and states: "ACE inhibitors or ARBs are the preferred agents for hypertensive patients with diabetic kidney disease or proteinuric CKD" [5]. Losartan at doses of 50 mg to 100 mg once daily satisfies that recommendation and is available in Arkansas pharmacies in both 25 mg, 50 mg, and 100 mg tablet strengths.

Arkansas Prescribing Authority: Who Can Write the Prescription

Any Arkansas-licensed MD, DO, NP, or PA with prescriptive authority can legally prescribe losartan, which is a non-controlled Rx-only medication. Arkansas Code § 17-87-310 grants advanced practice registered nurses (APRNs) full prescriptive authority under a collaborative practice agreement [6]. Physician assistants prescribe under a supervisory agreement per Arkansas Code § 17-105-101 [7].

Prescribers do not need a DEA number to prescribe losartan because it carries no controlled-substance scheduling. The practical result is that telehealth NPs and PAs can prescribe losartan in Arkansas without the additional DEA-registration step required for Schedule II, IV drugs.

The Arkansas State Medical Board explicitly permits synchronous audio-video telehealth encounters to establish a valid patient-physician relationship, which satisfies the state's prescribing standard [8]. An asynchronous (store-and-forward) encounter may be sufficient for straightforward hypertension management, though individual telehealth platforms vary in how they implement this provision. Patients should confirm that the platform they choose uses licensed Arkansas providers.

How to Get a Losartan Prescription in Arkansas: Four Pathways

Pathway 1: In-person primary care or internal medicine visit. A blood pressure reading, a basic metabolic panel (BMP), and a brief history are typically sufficient for same-visit prescribing. Most major Arkansas cities have same-day or next-day appointments at federally qualified health centers (FQHCs) if a patient lacks an established PCP [9].

Pathway 2: Arkansas-licensed telehealth provider. Platforms that maintain Arkansas-licensed physicians, NPs, or PAs can complete a video visit and send an electronic prescription to the patient's preferred pharmacy within hours. The Arkansas Telemedicine Act requires the telehealth provider to be licensed in Arkansas or to meet an exemption under a multistate compact [10]. The Interstate Medical Licensure Compact (IMLC) covers physicians, and the Nurse Licensure Compact (NLC) covers RNs and APRNs from member states.

Pathway 3: Transfer of an existing prescription. If a patient moving to Arkansas already has a losartan prescription from another state, federal law (21 CFR § 1306.25) and Arkansas Pharmacy Practice Act rules allow a pharmacist to transfer the prescription one time between non-controlled drug pharmacies [11]. The receiving Arkansas pharmacist contacts the out-of-state pharmacy to verify and transfer the remaining refills.

Pathway 4: Urgent care or retail clinic walk-in. Hypertension is within scope for most Arkansas urgent care centers and retail clinics. A same-day prescription is possible if blood pressure is elevated and no contraindications are identified. Labs may be ordered concurrently, with the prescriber reviewing results before the first refill.

Labs and Workup Required Before Starting Losartan

A baseline BMP is the minimum recommended workup before initiating losartan, because the drug can raise serum potassium and reduce eGFR, particularly in patients with pre-existing kidney disease or concurrent NSAID use [12]. The FDA label specifies monitoring of serum electrolytes and creatinine at the start of treatment and periodically thereafter [1].

Specific values that affect prescribing decisions include:

• Serum potassium above 5.0 mEq/L warrants caution or dose adjustment.
• eGFR <30 mL/min/1.73m² does not contraindicate losartan but requires closer titration.
• Creatinine rise of more than 30% above baseline after starting therapy may indicate renal artery stenosis and should prompt re-evaluation [13].

A 2021 pharmacovigilance analysis published in PLOS ONE (N=47,309 ARB initiators) found that hyperkalemia requiring hospitalization occurred in 1.4% of patients with baseline CKD stage 3b or higher who started an ARB, compared with 0.3% in patients with normal kidney function (P<0.001) [14]. That data supports obtaining a baseline BMP in all patients, not only those with known CKD.

Blood pressure should be measured at rest in both arms at the first visit. The 2023 ACC/AHA guideline recommends confirming hypertension with out-of-office measurements (home monitoring or ambulatory blood pressure monitoring) before starting drug therapy when the in-office reading is between 130/80 and 150/95 mmHg [5].

Pregnancy testing is appropriate for women of reproductive age because losartan carries an FDA Black Box Warning for fetal harm: "Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. Discontinue losartan as soon as pregnancy is detected" [1].

Telehealth Prescribing for Losartan in Arkansas: What to Expect

An Arkansas telehealth encounter for losartan typically follows this sequence. First, the patient completes an intake form documenting blood pressure readings (home cuff readings from the prior two weeks are accepted by most platforms), medication history, and relevant comorbidities. Second, a synchronous video call with the licensed Arkansas provider lasts 10 to 15 minutes. Third, the provider sends an e-prescription to the patient's chosen Arkansas pharmacy or to a mail-order pharmacy that ships to Arkansas addresses.

Turnaround from booking to prescription receipt at a local pharmacy can be as short as two to four hours for platforms with available same-day appointment slots. Mail-order fulfillment typically adds two to five business days.

Arkansas telehealth law does not require an in-person visit before prescribing a non-controlled chronic-disease medication such as losartan, provided the telehealth encounter meets the standard of care [8]. This is a meaningful distinction: patients in rural counties such as Lee, Chicot, or Desha, where physician-to-population ratios are below the state median, can access a losartan prescription without driving to a metro area [15].

The HealthRX clinical team uses a four-criteria readiness checklist before issuing a telehealth losartan prescription: (1) documented blood pressure above 130/80 mmHg on at least two separate readings, (2) baseline BMP completed within the prior 90 days or ordered concurrently, (3) absence of bilateral renal artery stenosis by history, and (4) confirmed negative pregnancy test or reliable contraception for women of reproductive potential. Patients meeting all four criteria can receive same-visit prescribing; those missing criterion 2 receive a 30-day supply bridging prescription contingent on lab return within 14 days.

Arkansas Medicaid and Insurance Coverage for Losartan

Arkansas Medicaid (Arkansas DHS) lists generic losartan on its Preferred Drug List (PDL) [16]. Coverage for the hypertension indication is straightforward, typically requiring only a current diagnosis code (ICD-10 I10). Coverage for diabetic nephropathy (ICD-10 N08) and heart failure (ICD-10 I50.x) may require prior authorization (PA) documenting the specific indication, serum creatinine or eGFR values, and confirmation that the prescriber has reviewed relevant labs.

PA documentation for Arkansas Medicaid generally includes:

• Prescriber NPI and Arkansas Medicaid provider number
• ICD-10 diagnosis code with supporting lab values (creatinine, urine albumin-to-creatinine ratio for nephropathy)
• Attestation that ACE inhibitor therapy was either tried and not tolerated or is contraindicated (for some payers)

Commercial insurers and most Medicare Part D plans cover generic losartan at Tier 1 without PA for hypertension. The average Tier 1 copay for a 30-day supply across Arkansas Part D plans in 2024 was $3.40 according to CMS plan-finder data [17].

Cash-pay patients can purchase 30 tablets of generic losartan 50 mg for $10 to $15 at Walmart, Walgreens, and CVS locations across Arkansas using GoodRx or similar discount cards, making insurance approval a lower priority for many patients compared with higher-cost medications [18].

503A Compounding Pharmacies and Losartan in Arkansas

Arkansas-licensed 503A pharmacies can compound losartan into non-commercially-available forms, such as oral suspensions for pediatric patients or patients with dysphagia who cannot swallow tablets. Compounding must be based on a valid patient-specific prescription; 503A pharmacies cannot compound for office stock or speculative distribution [19].

The FDA's current guidance on compounding of losartan notes that commercially available tablet strengths (25 mg, 50 mg, 100 mg) are adequate for most adult patients, and compounding the same strength/form as the commercially available product is generally not permitted under FDCA § 503A unless the prescriber documents a specific clinical need [19].

Losartan potassium as an oral suspension (1 mg/mL) is actually available as a commercially manufactured product (Cozaar oral suspension compounded by specialty pharmacies under the FDA label), which further limits the 503A compounding rationale in most adult cases [1]. Pediatric nephrologists in Arkansas most commonly rely on this route for children with CKD or Alport syndrome.

Titration, Monitoring, and Follow-Up After Starting Losartan in Arkansas

The FDA-approved starting dose for hypertension is 50 mg once daily. Patients who are volume-depleted (for example, those on high-dose diuretics or with active diarrhea) should start at 25 mg once daily to reduce the risk of first-dose hypotension [1]. The dose may be titrated to 100 mg once daily after two to four weeks if blood pressure remains above target.

For diabetic nephropathy, the FDA label specifically studied losartan 50 mg titrated to 100 mg once daily in the RENAAL trial (N=1,513), which found that losartan reduced the risk of doubling of serum creatinine by 25% and end-stage renal disease by 28% compared with placebo (P<0.02 for both endpoints) [20]. Arkansas providers managing patients with type 2 diabetes and persistent albuminuria should reference RENAAL dosing rather than defaulting to the lower hypertension dose.

Follow-up lab work (repeat BMP) is recommended two to four weeks after initiation and after any dose increase [12]. Stable patients on chronic losartan therapy typically have BMP monitoring every six to twelve months per the ACC/AHA chronic kidney disease management framework [5].

Drug interactions warrant review at every refill. Concurrent use of potassium-sparing diuretics (spironolactone, eplerenone) or potassium supplements significantly raises hyperkalemia risk [1]. NSAIDs blunt the antihypertensive and nephroprotective effects of losartan and should be minimized or replaced with acetaminophen where possible [13]. Aliskiren co-administration is contraindicated in patients with diabetes due to increased renal impairment and hyperkalemia risk per the FDA label update from 2012 [1].

Pharmacy Availability Across Arkansas

Major retail chains with Arkansas locations, including Walmart (headquartered in Bentonville, AR), Walgreens, CVS, Kroger Pharmacy, and Harps Food pharmacy, all stock generic losartan in 25 mg, 50 mg, and 100 mg tablets. Independent pharmacies in smaller towns such as Batesville, El Dorado, and Paragould also typically carry all three strengths.

Mail-order pharmacies that ship to Arkansas addresses include CVS Caremark, Express Scripts (Cigna), OptumRx, and Amazon Pharmacy. Standard mail delivery within Arkansas takes two to three business days; expedited shipping is available for an additional fee. A 90-day supply via mail order typically reduces per-pill cost by 20% to 30% compared with 30-day retail fills [17].

Patients who cannot afford losartan even at cash-pay discount prices may qualify for Merck's patient assistance program (Merck Helps) for branded Cozaar, though generic availability makes this route rarely necessary [21]. The Arkansas Department of Human Services also administers the ARKids First and ConnectCare programs, which cover generic losartan for qualifying low-income children and adults [16].

Transferring a Losartan Prescription to Arkansas

Federal transfer rules under 21 CFR § 1306.25 allow a one-time transfer of a non-controlled prescription between pharmacies [11]. In practice, a patient moving to Arkansas calls their new Arkansas pharmacy, provides the out-of-state pharmacy name and phone number, and the pharmacists complete the transfer directly. The transferred prescription retains the original refill count minus any refills already dispensed.

Some pharmacy chains (CVS, Walgreens, Walmart) allow transfers within their own network electronically, which can complete in minutes. Cross-chain transfers require a direct pharmacist-to-pharmacist phone call and may take a few hours.

If the original prescription had zero refills remaining, the receiving pharmacist cannot transfer it. The patient must contact the original prescriber (or a new Arkansas provider) for a new prescription. Telehealth platforms can write a new Arkansas prescription in this scenario, typically within the same business day [8].

Electronic prescriptions transmitted via Surescripts (the national e-prescribing network) go directly to the Arkansas pharmacy of choice and do not require a physical transfer at all. This is now the standard workflow for most telehealth platforms operating in Arkansas.